Capital Research Global Investors Acquires 194,895 Shares of Integer Holdings Co. (NYSE:ITGR)

Capital Research Global Investors raised its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 16.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,410,803 shares of the medical equipment provider's stock after purchasing an additional 194,895 shares during the quarter. Capital Research Global Investors owned 4.21% of Integer worth $186,960,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Loomis Sayles & Co. L P raised its stake in Integer by 3.8% during the 4th quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock valued at $74,041,000 after buying an additional 20,688 shares during the last quarter. Congress Asset Management Co. lifted its holdings in Integer by 2.0% in the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock valued at $66,041,000 after acquiring an additional 9,565 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Integer by 1.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider's stock worth $54,146,000 after purchasing an additional 4,559 shares during the last quarter. Lord Abbett & CO. LLC increased its position in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after purchasing an additional 9,754 shares during the last quarter. Finally, Tributary Capital Management LLC lifted its stake in shares of Integer by 0.8% in the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock worth $38,103,000 after purchasing an additional 2,289 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Trading Up 1.6 %

Shares of NYSE ITGR traded up $1.93 during trading hours on Friday, hitting $123.39. 450,566 shares of the company traded hands, compared to its average volume of 351,464. The stock has a market capitalization of $4.31 billion, a price-to-earnings ratio of 36.72, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. The company's 50 day moving average price is $119.93 and its 200 day moving average price is $130.30. Integer Holdings Co. has a 12 month low of $104.93 and a 12 month high of $146.36. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. On average, equities research analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have weighed in on ITGR. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Truist Financial set a $150.00 price target on Integer in a report on Friday. KeyCorp decreased their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday. Raymond James raised their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday. Finally, Benchmark decreased their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $145.56.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.